StockMacro
Menu

OneMedNet

$4.70 -47% in 6 monthsMarket cap $29.1M

ONMD on XNAS, Health Care, OneMedNet Corp, job postings

Measures activity, not value. Not investment advice.

Revenue rose 365% to $2.3M over 12 months, but cash is just $137K against a $10.4M loss.

  • GoodInsiders bought $1.1M and sold $103K in 90 days
  • BadInstitutional holders fell to 13 from 22, down 41%

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Industry
Services-commercial physical & biological research (Health Care)
Employees
23
Website
onemednet.com
Listed
Nasdaq, US
Last results
9 Nov 2026
Next results
no estimate
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.0M, net loss $2.7M.
Quarter to 31 Dec 2021: revenue –, net income -$464KQuarter to 31 Mar 2022: revenue –, net income $2.2MQuarter to 30 Jun 2022: revenue –, net income $950KQuarter to 30 Sep 2022: revenue –, net income -$153KQuarter to 31 Dec 2022: revenue $264K, net income -$2.7MQuarter to 31 Dec 2022: revenue $264K, net income -$2.7MQuarter to 31 Mar 2023: revenue $200K, net income -$86KQuarter to 31 Mar 2023: revenue $200K, net income -$86KQuarter to 30 Jun 2023: revenue $173K, net income -$5KQuarter to 30 Jun 2023: revenue $173K, net income -$5KQuarter to 30 Sep 2023: revenue $326K, net income -$1.7MQuarter to 30 Sep 2023: revenue $326K, net income -$1.7MQuarter to 31 Dec 2023: revenue $341K, net income –Quarter to 31 Mar 2024: revenue $248K, net income -$2.1MQuarter to 31 Mar 2024: revenue $248K, net income -$2.1MQuarter to 30 Jun 2024: revenue $227K, net income -$3.6MQuarter to 30 Jun 2024: revenue $227K, net income -$3.6MQuarter to 30 Sep 2024: revenue $142K, net income -$2.1MQuarter to 30 Sep 2024: revenue $142K, net income -$2.1MQuarter to 31 Dec 2024: revenue $26K, net income -$2.4MQuarter to 31 Dec 2024: revenue $26K, net income -$2.4MQuarter to 31 Mar 2025: revenue $137K, net income -$1.9MQuarter to 31 Mar 2025: revenue $137K, net income -$1.9MQuarter to 30 Jun 2025: revenue $155K, net income $3.0MQuarter to 30 Jun 2025: revenue $155K, net income $3.0MQuarter to 30 Sep 2025: revenue $177K, net income -$741KQuarter to 30 Sep 2025: revenue $177K, net income -$741KQuarter to 31 Dec 2025: revenue –, net income -$3.1MQuarter to 31 Mar 2026: revenue $96K, net income -$2.5MQuarter to 31 Mar 2026: revenue $96K, net income -$2.5MQuarter to 30 Jun 2026: revenue $292K, net income -$2.2MQuarter to 30 Jun 2026: revenue $292K, net income -$2.2MQuarter to 30 Sep 2026: revenue $1.0M, net income -$2.7MQuarter to 30 Sep 2026: revenue $1.0M, net income -$2.7M
31 Dec 2021RevenueNet incomeNet losstallest bar $3.6M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$1.0M-$2.7M
30 Jun 2026$292K-$2.2M
31 Mar 2026$96K-$2.5M
31 Dec 2025–-$3.1M
30 Sep 2025$177K-$741K
30 Jun 2025$155K$3.0M
31 Mar 2025$137K-$1.9M
31 Dec 2024$26K-$2.4M
30 Sep 2024$142K-$2.1M
30 Jun 2024$227K-$3.6M
31 Mar 2024$248K-$2.1M
31 Dec 2023$341K–
30 Sep 2023$326K-$1.7M
30 Jun 2023$173K-$5K
31 Mar 2023$200K-$86K
31 Dec 2022$264K-$2.7M
30 Sep 2022–-$153K
30 Jun 2022–$950K
31 Mar 2022–$2.2M
31 Dec 2021–-$464K
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $2.3M $495K
Revenue growthRevenue of the last 12 months compared with the 12 months before. +365% +3.4%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$10.4M -$2.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. -49.7% -144% 63.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -440% – 4.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -453% -411% 1.0%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – -16.5%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $137K $149K
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – $388K
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – $239K
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.00
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 57.9
P/SPrice to sales: market cap divided by revenue of the last 12 months. 12.7 4.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 4.4
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. – 4.4

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
OneMedNetONMD (this company) $29.1Mloss12.7+365%-453%
IB AcquisitionIBAC $53.1Mloss–––
MaxCyteMXCT $141.5Mloss4.1-0.1%-81.4%
bioAffinity TechnologiesBIAF $3.0Mloss0.54-18%-279%
NRC HealthNRC $533.9M82.93.7+3.4%4.5%
NanoViricidesNNVC $29.1Mloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$987K

bought $1.1M, sold $103K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-41%

13 13F filers vs 22

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

27%

1.7M shares held by 13F filers (30 Sep 2026) of 6.2M outstanding (16 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.1%

133K shares sold short (30 Oct 2026) of 6.2M outstanding (16 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.8

133K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-12%

151K shares sold short in the report before, 133K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

32%

32% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 39%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

9

9 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

9 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $4.70 on 20 Nov 2026, -57% over 12 months (12-month range $3.93 to $19.50)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $3.9M in the last 12 months (the 12 months before: $2.1M).
Revenue per quarter. Revenue $1.0M in the latest quarter, +478% on a year earlier.
Capital spending per quarter. Capital spending $1K in the latest quarter.
Institutional holders (13F filers). 13 13F filers reported holding it in the latest 13F quarter, -24% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
23 Sep 20268-K and other filingsDirector or officer change
23 Sep 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Aug 2026Sharp changeShort interest spike: short interest spike, 1.8M vs usual 483K (2026-07-31); 1.8x the same period a year earlier
8 Jul 20268-K and other filingsRegistered new securities for sale (S-1)
1 Jul 20268-K and other filingsRegistered new securities for sale (S-1)
18 Jun 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 4 filing(s) in 30 days, value_usd total 481K)
20 Apr 20268-K and other filingsDelisting notice or listing transfer
31 Mar 2026Sharp changeShort interest spike: short interest spike, 1.7M vs usual 245K (2026-03-13); 27.2x the same period a year earlier
27 Nov 2025Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 6 filing(s) in 30 days, value_usd total 2.1M)
7 Nov 20258-K and other filingsDirector or officer change
7 Nov 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Oct 2025Sharp changeShort interest spike: short interest spike, 698K vs usual 112K (2025-10-15); 2.3x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 709K vs usual 112K (2025-09-30); 2.4x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 842K vs usual 112K (2025-09-15); 3.4x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 1.6M vs usual 112K (2025-08-29); 6.1x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 3.3M vs usual 112K (2025-08-15); 10.6x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 995K vs usual 112K (2025-07-31); 2.6x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 1.2M vs usual 112K (2025-07-15); 5.7x the same period a year earlier
12 Jul 20258-K and other filingsRegistered new securities for sale (S-1)
25 Jun 20258-K and other filingsRegistered new securities for sale (S-1)
15 Apr 20258-K and other filingsDelisting notice or listing transfer
1 Apr 20258-K and other filingsReport will be filed late
14 Mar 20258-K and other filingsDelisting notice or listing transfer
3 Mar 20258-K and other filingsDirector or officer change
6 Feb 20258-K and other filingsDirector or officer change
6 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Feb 20258-K and other filingsRegistered new securities for sale (S-1)
27 Nov 20248-K and other filingsDelisting notice or listing transfer
15 Nov 20248-K and other filingsReport will be filed late
5 Nov 20248-K and other filingsEarlier financial statements can no longer be relied on
17 Oct 20248-K and other filingsDelisting notice or listing transfer
15 Oct 20248-K and other filingsDelisting notice or listing transfer
5 Oct 20248-K and other filingsDirector or officer change
12 Sep 20248-K and other filingsDelisting notice or listing transfer
30 Aug 20248-K and other filingsDirector or officer change
16 Aug 20248-K and other filingsDelisting notice or listing transfer
14 Aug 20248-K and other filingsDirector or officer change
14 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Aug 20248-K and other filingsPrivate placement of securities (Form D)
24 Jun 20248-K and other filingsDelisting notice or listing transfer
21 Jun 20248-K and other filingsA major agreement ended
14 Jun 20248-K and other filingsDelisting notice or listing transfer
4 Jun 20248-K and other filingsEarlier financial statements can no longer be relied on
4 Jun 20248-K and other filingsChanged its auditor
14 May 20248-K and other filingsReport will be filed late
10 May 20248-K and other filingsChanged its auditor
7 May 20248-K and other filingsRegistered new securities for sale (S-1)
17 Apr 20248-K and other filingsRegistered new securities for sale (S-1)
11 Apr 20248-K and other filingsPrivate placement of securities (Form D)
2 Apr 20248-K and other filingsDirector or officer change
2 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Apr 20248-K and other filingsReport will be filed late
29 Mar 20248-K and other filingsDelisting notice or listing transfer
9 Feb 20248-K and other filingsDelisting notice or listing transfer
3 Jan 20248-K and other filingsChanged its auditor
19 Dec 20238-K and other filingsRegistered new securities for sale (S-1)
15 Dec 20238-K and other filingsEarlier financial statements can no longer be relied on
14 Nov 20238-K and other filingsReport will be filed late
13 Nov 20238-K and other filingsDirector or officer change
13 Nov 20238-K and other filingsCompleted an acquisition or asset sale
13 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 May 20238-K and other filingsReport will be filed late
14 Nov 20228-K and other filingsReport will be filed late
31 Mar 20228-K and other filingsReport will be filed late
Insider net buying (open market)
Month from 1 Jan 2023: -$1.0M published
Month from 1 Nov 2025: $2.1M published
Month from 1 Dec 2025: -$218K published
Month from 1 Apr 2026: $1.5M published
Month from 1 May 2026: $250K published
Month from 1 Jun 2026: $352K published
Month from 1 Aug 2026: $1.0M published
Month from 1 Sep 2026: $90K published
Month from 1 Oct 2026: $897K published
Revenue per quarter
Quarter ended 31 Dec 2022: $264K; public on 10 Apr 2024
Quarter ended 31 Mar 2023: $200K; public on 6 Dec 2024
Quarter ended 30 Jun 2023: $173K; public on 12 Dec 2024
Quarter ended 30 Sep 2023: $326K; public on 18 Dec 2024
Quarter ended 31 Dec 2023: $341K, +29% on a year earlier; public on 10 Apr 2024
Quarter ended 31 Mar 2024: $248K, +24% on a year earlier; public on 6 Dec 2024
Quarter ended 30 Jun 2024: $227K, +31% on a year earlier; public on 12 Dec 2024
Quarter ended 30 Sep 2024: $142K, -56% on a year earlier; public on 18 Dec 2024
Quarter ended 31 Dec 2024: $26K, -92% on a year earlier; public on 16 Apr 2025
Quarter ended 31 Mar 2025: $137K, -45% on a year earlier; public on 15 May 2025
Quarter ended 30 Jun 2025: $155K, -32% on a year earlier; public on 14 Aug 2025
Quarter ended 30 Sep 2025: $177K, +25% on a year earlier; public on 15 Nov 2025
Quarter ended 31 Mar 2026: $96K, -30% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2026: $292K, +88% on a year earlier; public on 15 Aug 2026
Quarter ended 30 Sep 2026: $1.0M, +478% on a year earlier; public on 17 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2022: $9K; public on 10 Apr 2024
Quarter ended 30 Sep 2023: $22K; public on 21 Nov 2023
Quarter ended 31 Dec 2023: $15K, +60% on a year earlier; public on 10 Apr 2024
Quarter ended 31 Mar 2024: $6K; public on 6 Dec 2024
Quarter ended 30 Jun 2024: $1K; public on 12 Dec 2024
Quarter ended 31 Mar 2025: $5K, -17% on a year earlier; public on 15 May 2025
Quarter ended 30 Jun 2025: $3K, +200% on a year earlier; public on 14 Aug 2025
Quarter ended 31 Dec 2025: $5K; public on 31 Mar 2026
Quarter ended 31 Mar 2026: $2K, -60% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2026: $9K, +200% on a year earlier; public on 15 Aug 2026
Quarter ended 30 Sep 2026: $1K; public on 17 Nov 2026
Institutional holders (13F filers)
31 Dec 2023 report: 6; public on 14 Feb 2024
31 Mar 2024 report: 6; public on 15 May 2024
30 Jun 2024 report: 13; public on 14 Aug 2024
30 Sep 2024 report: 19; public on 14 Nov 2024
31 Dec 2024 report: 17; public on 14 Feb 2025
31 Mar 2025 report: 16; public on 15 May 2025
30 Jun 2025 report: 14; public on 14 Aug 2025
30 Sep 2025 report: 17; public on 14 Nov 2025
31 Dec 2025 report: 22; public on 17 Feb 2026
31 Mar 2026 report: 21; public on 15 May 2026
30 Jun 2026 report: 22; public on 14 Aug 2026
30 Sep 2026 report: 13; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $1.0M (13 Oct 2026), 10.0× its normal reading; higher than 77% of its own history.
  • Clustered insider buying: had 3 insiders buy $481K of its shares on the open market within 30 days (4 filings) Public on 18 Jun 2026.
  • Short interest spike: had 1.8M shares sold short in the 31 Jul 2026 report, 1.8× the same report last year Public on 12 Aug 2026.
  • Revenue per quarter: Revenue $1.0M in the latest quarter, +478% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 22 insider trades

Last 90 days: 2 sales, $103K; 3 purchases, $1.1M. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 Oct 2026Thomas KosasaDirector, 10% ownerBuy129,758$5.78$750KForm 4
13 Oct 2026Jeffrey YuChief Medical OfficerBuy45,126$5.54$250KForm 4
9 Oct 2026Robert Lawrence GoldenChief Financial OfficerSell8,500$6.50$55KForm 4
9 Oct 2026Aaron GreenChief Executive OfficerSell6,667$7.16$48KForm 4
14 Sep 2026Jeffrey YuChief Medical OfficerBuy142,857$0.63$90KForm 4
7 Aug 2026Thomas KosasaDirector, 10% ownerBuy1,449,275$0.69$1.0MForm 4
24 Jun 2026Jeffrey YuChief Medical OfficerBuy158,730$0.63$100KForm 4
24 Jun 2026Aaron GreenChief Executive OfficerBuy36,650$0.57$21KForm 4

13 institutions reported shares at the end of Q3 2026, 27% of the shares outstanding; 1 opened a position, 10 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Savant Capital, LLC3.2M51.4%$8.4M-4.0M-56%
Vanguard Capital Management LLC115K1.86%$667K-1.0M-90%
Geode Capital Management, LLC29K0.46%$166K-306K-91%
State Street Corp15K0.24%$86K-102K-87%
Vanguard Fiduciary Trust Co14K0.22%$80K-124K-90%
BlackRock, Inc.12K0.19%$69K-109K-90%
Discovery Capital Management, LLC / CT11K0.18%$65K-101K-90%
PNC Financial Services Group, Inc.10K0.17%$60K-93K-90%
UBS Group AG2,0790.03%$12K-14K-87%
Tower Research Capital LLC (TRC)1,6300.03%$9K-3,111-66%

Company events

All 64 company events

In 12 months: 2 share registrations, 1 delisting notice, 1 major agreement, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
23 Sep 2026Director or officer changeSame filing: shareholder vote results8-K
8 Jul 2026Registered new securities for sale (S-1)S-1/A
1 Jul 2026Signed a major agreement8-K
1 Jul 2026Registered new securities for sale (S-1)S-1
20 Apr 2026Delisting notice or listing transfer8-K
7 Nov 2025Director or officer change8-K
11 Jul 2025Registered new securities for sale (S-1)S-1/A
24 Jun 2025Signed a major agreementSame filing: sold shares privately8-K

The 5 newest of 45 articles that name the company.

Timeline
Kind of data

Several things at once

Two or more unrelated kinds of records unusual within 30 days

27 Nov 2025confirmed

Confirmed across sources Insiders and Short interest and volume

OneMedNet (ONMD): had 698K shares sold short in the 15 Oct 2025 report, 2.3× the same report last year, while it had 4 insiders buy $2.1M of its shares on the open market within 30 days (6 filings). Two unrelated kinds of activity within 29 days.

  • Short interest and volume: Short interest spike, became public on 25 Oct 2025
  • Insiders: Clustered insider buying, became public on 27 Nov 2025
2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K2025-08-15: 3.3M2025-08-29: 1.6M2025-09-15: 842K2025-09-30: 709K2025-10-15: 698K
The 15 Oct 2025 report against the 24 reports before it. this reportearliernormal: 112K
See the evidence (2 changes)

Short interest and volume: Short interest spike became public on 25 Oct 2025

OneMedNet had 698K shares sold short in the 15 Oct 2025 report, 2.3× the same report last year.

This period
698K (the 15 Oct 2025 report)
Normal report (median of 24 earlier)
112K
Typical spread (median absolute deviation)
69K
How far from its usual level
+5.7
Same report last year
298K
History used
700 days
2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K2025-08-15: 3.3M2025-08-29: 1.6M2025-09-15: 842K2025-09-30: 709K2025-10-15: 698K
the 15 Oct 2025 report24 earlier reportsnormal: 112K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Insiders: Clustered insider buying became public on 27 Nov 2025

OneMedNet had 4 insiders buy $2.1M of its shares on the open market within 30 days (6 filings).

Independent buyers
4
Purchase filings (Form 4, code P)
6
Total bought
$2.1M
Window
28 Oct 2025 to 27 Nov 2025

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 14 Oct 2026Insiders record

    Kosasa Thomas (director) bought 129,758 shares of ONMD ($750,001) (dated 13 Oct 2026)

  2. 14 Oct 2026Insiders record

    Yu Jeffrey (Chief Medical Officer) bought 45,126 shares of ONMD ($249,998) (dated 13 Oct 2026)

  3. 23 Sep 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 23 Sep 2026Filings record

    Director or officer change

  5. 15 Sep 2026Insiders record

    Yu Jeffrey (Chief Medical Officer) bought 142,857 shares of ONMD ($90,000) (dated 14 Sep 2026)

  6. 12 Aug 2026Short interest and volume change

    had 1.8M shares sold short in the 31 Jul 2026 report, 1.8× the same report last year.

    Same report last year: 995K; its normal report is 483K.

    See the evidence
    This period
    1.8M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    483K
    Typical spread (median absolute deviation)
    254K
    How far from its usual level
    +3.5
    Same report last year
    995K
    History used
    989 days
    2025-07-31: 995K2025-08-15: 3.3M2025-08-29: 1.6M2025-09-15: 842K2025-09-30: 709K2025-10-15: 698K2025-10-31: 266K2025-11-14: 119K2025-11-28: 219K2025-12-15: 424K2025-12-31: 135K2026-01-15: 135K2026-01-30: 224K2026-02-13: 327K2026-02-27: 315K2026-03-13: 1.7M2026-03-31: 757K2026-04-15: 620K2026-04-30: 744K2026-05-15: 558K2026-05-29: 457K2026-06-15: 508K2026-06-30: 233K2026-07-15: 346K2026-07-31: 1.8M
    the 31 Jul 2026 report24 earlier reportsnormal: 483K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 8 Aug 2026Insiders record

    Kosasa Thomas (director) bought 1,449,275 shares of ONMD ($1.0M) (dated 7 Aug 2026)

  8. 8 Jul 2026Filings record

    Registered new securities for sale (S-1)

  9. 1 Jul 2026Filings record

    Registered new securities for sale (S-1)

  10. 25 Jun 2026Insiders record

    Yu Jeffrey (Chief Medical Officer) bought 158,730 shares of ONMD ($100,000) (dated 24 Jun 2026)

  11. 25 Jun 2026Insiders record

    Green Aaron (Chief Executive Officer) bought 36,650 shares of ONMD ($20,890) (dated 24 Jun 2026)

  12. 18 Jun 2026Insiders change

    had 3 insiders buy $481K of its shares on the open market within 30 days (4 filings).

    Who bought: Kosasa Thomas, Green Aaron, Yu Jeffrey.

    See the evidence (4 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    4
    Total bought
    $481K
    Window
    19 May 2026 to 18 Jun 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  13. 18 Jun 2026Insiders record

    Yu Jeffrey (Chief Medical Officer) bought 172,414 shares of ONMD ($100,000) (dated 17 Jun 2026)

  14. 17 Jun 2026Insiders record

    Green Aaron (Chief Executive Officer) bought 55,622 shares of ONMD ($30,774) (dated 16 Jun 2026)

  15. 16 Jun 2026Insiders record

    Kosasa Thomas (director) bought 158,730 shares of ONMD ($100,000) (dated 15 Jun 2026)

  16. 21 May 2026Insiders record

    Kosasa Thomas (director) bought 268,817 shares of ONMD ($250,000) (dated 20 May 2026)

  17. 25 Apr 2026Insiders record

    Kosasa Thomas (director) bought 876,136 shares of ONMD ($749,999) (dated 24 Apr 2026)

  18. 25 Apr 2026Insiders record

    Yu Jeffrey (Chief Medical Officer) bought 903,614 shares of ONMD ($750,000) (dated 24 Apr 2026)

  19. 20 Apr 2026Filings record

    Delisting notice or listing transfer

  20. 25 Mar 2026Short interest and volume change

    had 1.7M shares sold short in the 13 Mar 2026 report, 27× the same report last year.

    Same report last year: 63K; its normal report is 245K.

    See the evidence
    This period
    1.7M (the 13 Mar 2026 report)
    Normal report (median of 24 earlier)
    245K
    Typical spread (median absolute deviation)
    180K
    How far from its usual level
    +5.5
    Same report last year
    63K
    History used
    849 days
    2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K2025-08-15: 3.3M2025-08-29: 1.6M2025-09-15: 842K2025-09-30: 709K2025-10-15: 698K2025-10-31: 266K2025-11-14: 119K2025-11-28: 219K2025-12-15: 424K2025-12-31: 135K2026-01-15: 135K2026-01-30: 224K2026-02-13: 327K2026-02-27: 315K2026-03-13: 1.7M
    the 13 Mar 2026 report24 earlier reportsnormal: 245K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 27 Nov 2025several at once

    had 698K shares sold short in the 15 Oct 2025 report, 2.3× the same report last year, while it had 4 insiders buy $2.1M of its shares on the open market within 30 days (6 filings). Two unrelated kinds of activity within 29 days.

    See the evidence (2 changes)

    Short interest and volume: Short interest spike became public on 25 Oct 2025

    OneMedNet had 698K shares sold short in the 15 Oct 2025 report, 2.3× the same report last year.

    This period
    698K (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    69K
    How far from its usual level
    +5.7
    Same report last year
    298K
    History used
    700 days
    2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K2025-08-15: 3.3M2025-08-29: 1.6M2025-09-15: 842K2025-09-30: 709K2025-10-15: 698K
    the 15 Oct 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Insiders: Clustered insider buying became public on 27 Nov 2025

    OneMedNet had 4 insiders buy $2.1M of its shares on the open market within 30 days (6 filings).

    Independent buyers
    4
    Purchase filings (Form 4, code P)
    6
    Total bought
    $2.1M
    Window
    28 Oct 2025 to 27 Nov 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  22. 27 Nov 2025Insiders change

    had 4 insiders buy $2.1M of its shares on the open market within 30 days (6 filings).

    Who bought: Yu Jeffrey, Casaburi Eric, Kosasa Thomas, Golden Robert Lawrence.

    See the evidence (6 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    6
    Total bought
    $2.1M
    Window
    28 Oct 2025 to 27 Nov 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  23. 27 Nov 2025Insiders record

    Golden Robert Lawrence (Chief Financial Officer) bought 300 shares of ONMD ($513) (dated 26 Nov 2025)

  24. 27 Nov 2025Insiders record

    Yu Jeffrey (Chief Medical Officer) bought 22,762 shares of ONMD ($17,192) (dated 26 Nov 2025)

  25. 27 Nov 2025Insiders record

    Kosasa Thomas (director) bought 1,879,871 shares of ONMD ($1.0M) (dated 26 Nov 2025)

  26. 27 Nov 2025Insiders record

    Yu Jeffrey (Chief Medical Officer) bought 2,010,479 shares of ONMD ($959,586) (dated 26 Nov 2025)

  27. 27 Nov 2025Insiders record

    Casaburi Eric (director) bought 20,475 shares of ONMD ($39,262) (dated 26 Nov 2025)

  28. 27 Nov 2025Insiders record

    Yu Jeffrey (Chief Medical Officer) bought 9,540 shares of ONMD ($8,929) (dated 26 Nov 2025)

  29. 7 Nov 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 7 Nov 2025Filings record

    Director or officer change

  31. 25 Oct 2025Short interest and volume change

    had 698K shares sold short in the 15 Oct 2025 report, 2.3× the same report last year.

    Same report last year: 298K; its normal report is 112K.

    See the evidence
    This period
    698K (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    69K
    How far from its usual level
    +5.7
    Same report last year
    298K
    History used
    700 days
    2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K2025-08-15: 3.3M2025-08-29: 1.6M2025-09-15: 842K2025-09-30: 709K2025-10-15: 698K
    the 15 Oct 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 10 Oct 2025Short interest and volume change

    had 709K shares sold short in the 30 Sep 2025 report, 2.4× the same report last year.

    Same report last year: 300K; its normal report is 112K.

    See the evidence
    This period
    709K (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    69K
    How far from its usual level
    +5.8
    Same report last year
    300K
    History used
    685 days
    2024-09-30: 300K2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K2025-08-15: 3.3M2025-08-29: 1.6M2025-09-15: 842K2025-09-30: 709K
    the 30 Sep 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 25 Sep 2025Short interest and volume change

    had 842K shares sold short in the 15 Sep 2025 report, 3.4× the same report last year.

    Same report last year: 250K; its normal report is 112K.

    See the evidence
    This period
    842K (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    69K
    How far from its usual level
    +7.2
    Same report last year
    250K
    History used
    670 days
    2024-09-13: 250K2024-09-30: 300K2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K2025-08-15: 3.3M2025-08-29: 1.6M2025-09-15: 842K
    the 15 Sep 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 11 Sep 2025Short interest and volume change

    had 1.6M shares sold short in the 29 Aug 2025 report, 6.1× the same report last year.

    Same report last year: 262K; its normal report is 112K.

    See the evidence
    This period
    1.6M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    69K
    How far from its usual level
    +14.6
    Same report last year
    262K
    History used
    653 days
    2024-08-30: 262K2024-09-13: 250K2024-09-30: 300K2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K2025-08-15: 3.3M2025-08-29: 1.6M
    the 29 Aug 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 27 Aug 2025Short interest and volume change

    had 3.3M shares sold short in the 15 Aug 2025 report, 11× the same report last year.

    Same report last year: 309K; its normal report is 112K.

    See the evidence
    This period
    3.3M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    69K
    How far from its usual level
    +31.0
    Same report last year
    309K
    History used
    639 days
    2024-08-15: 309K2024-08-30: 262K2024-09-13: 250K2024-09-30: 300K2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K2025-08-15: 3.3M
    the 15 Aug 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  36. 12 Aug 2025Short interest and volume change

    had 995K shares sold short in the 31 Jul 2025 report, 2.6× the same report last year.

    Same report last year: 378K; its normal report is 112K.

    See the evidence
    This period
    995K (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    69K
    How far from its usual level
    +8.7
    Same report last year
    378K
    History used
    624 days
    2024-07-31: 378K2024-08-15: 309K2024-08-30: 262K2024-09-13: 250K2024-09-30: 300K2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M2025-07-31: 995K
    the 31 Jul 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 25 Jul 2025Short interest and volume change

    had 1.2M shares sold short in the 15 Jul 2025 report, 5.7× the same report last year.

    Same report last year: 212K; its normal report is 112K.

    See the evidence
    This period
    1.2M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    112K
    Typical spread (median absolute deviation)
    69K
    How far from its usual level
    +10.7
    Same report last year
    212K
    History used
    608 days
    2024-07-15: 212K2024-07-31: 378K2024-08-15: 309K2024-08-30: 262K2024-09-13: 250K2024-09-30: 300K2024-10-15: 298K2024-10-31: 179K2024-11-15: 278K2024-11-29: 112K2024-12-13: 113K2024-12-31: 57K2025-01-15: 59K2025-01-31: 121K2025-02-14: 112K2025-02-28: 71K2025-03-14: 63K2025-03-31: 42K2025-04-15: 32K2025-04-30: 28K2025-05-15: 75K2025-05-30: 75K2025-06-13: 87K2025-06-30: 2.0M2025-07-15: 1.2M
    the 15 Jul 2025 report24 earlier reportsnormal: 112K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 12 Jul 2025Filings record

    Registered new securities for sale (S-1) (dated 11 Jul 2025)

  39. 25 Jun 2025Filings record

    Registered new securities for sale (S-1) (dated 24 Jun 2025)

  40. 15 Apr 2025Filings record

    Delisting notice or listing transfer

Showing the newest 40 of 88 entries; narrow the window or the kind of data to see older ones.

Not listed: 67 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001849380
Ticker
ONMD
Domain
onemednet.com
Hq location
X0|SURREY|KT9 1 (1 unverified)
Name
Data Knights Acquisition Corp., OneMedNet Corp
Uei
C7DGVMR894R3
  • SEC Form 13F institutional holdings108 data points31 Dec 2023 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)115 records9 Mar 2021 to 16 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)315 data points7 Feb 2021 to 16 Nov 2026
  • SEC Form 4 insider transactions22 records, 52 data points13 Jan 2023 to 13 Oct 2026
  • FINRA short interest (twice monthly)216 data points15 Nov 2023 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)1524 data points8 Nov 2023 to 20 Nov 2026
  • USASpending.gov federal awards18 data points30 Jul 2014 to 31 Mar 2020